广州白云山医药集团股份有限公司（H股代码：00874；A股代码：600332）于2026年2月3日发布2026年1月股份变动月报。公告显示，截至2026年1月31日，公司H股与A股的已发行股份数均未发生变化，股本结构保持稳定。
公司现有注册股本合计为人民币1,625,790,949元。其中，H股股本为219,900,000股，A股股本为1,405,890,949股。本月无新增发行、购回、注销或库藏股情况，股本总数自上月底以来保持不变。
同时，公司披露，1月内无任何股份期权、认股权证或可换股票据的变动，亦无其他协议或安排涉及已发行股份的变动。公司确认遵守香港联交所《上市规则》等相关法律法规，且截至本月末，公司H股的公众持股量符合适用要求。
本次月报由公司秘书黄雪贞签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.